Pharmabiz4h
US FDA approves Celltrion’s Stoboclo and Osenvelt biosimilars referencing Prolia and Xgeva
US FDA approves Celltrion’s Stoboclo and Osenvelt biosimilars referencing Prolia and Xgeva: Jersey City, New Jersey Wednesday, March 5, 2025, 18:00 Hrs [IST] Celltrion, a leadin ...
Pharmabiz5h
Ideaya Biosciences collaborates with ATTMOS to accelerate AI/ML-enabled drug discovery for unprecedented first-in-class oncology targets
Ideaya Biosciences collaborates with ATTMOS to accelerate AI/ML-enabled drug discovery for unprecedented first-in-class oncology targets: South San Francisco, California Wednesday ...
Pharmabiz6h
Osivax secures strategic funding to accelerate the development of its influenza vaccine candidates
Osivax secures strategic funding to accelerate the development of its influenza vaccine candidates: Lyon, France Wednesday, March 5, 2025, 16:00 Hrs [IST] Osivax, a biopharmaceuti ...
Pharmabiz7h
Neotia Bhagirathi Woman & Child Care Centre hosted NEOPEDICON 2025 focusing neonatal and paediatric clinical innovations
Neotia Bhagirathi Woman & Child Care Centre hosted NEOPEDICON 2025 focusing neonatal and paediatric clinical innovations: Our Bureau, Bengaluru Wednesday, March 5, 2025, 15:20 Hrs ...
Pharmabiz7h
CDSCO launches online registration for CROs
Gireesh Babu, New Delhi Wednesday, March 5, 2025, 14:45 Hrs [IST] With the registration of clinical research organisations (CROs) to b ...
Pharmabiz8h
Regenxbio closes strategic partnership with Nippon Shinyaku for MPS diseases
Regenxbio closes strategic partnership with Nippon Shinyaku for MPS diseases: Rockville, Maryland Wednesday, March 5, 2025, 14:00 Hrs [IST] Regenxbio Inc., a leading clinical-stag ...
Pharmabiz9h
Evotec announces key progress in neuroscience collaboration with Bristol Myers Squibb
Evotec announces key progress in neuroscience collaboration with Bristol Myers Squibb: Hamburg, Germany Wednesday, March 5, 2025, 13:00 Hrs [IST] Evotec SE, a life science company ...
Pharmabiz10h
New clinical trial map launched in the European Union
Amsterdam, The Netherlands Wednesday, March 5, 2025, 12:00 Hrs [IST] A new clinical trial map is now accessible from the pub ...
Pharmabiz11h
Omalizumab treats multi-food allergy better than oral immunotherapy: Study
Omalizumab treats multi-food allergy better than oral immunotherapy: Study: Bethesda, Maryland Wednesday, March 5, 2025, 11:00 Hrs [IST] A clinical trial has found that the medica ...
Pharmabiz12h
Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China
Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China: Ingelheim, Germany Wednesday, March 5, 2025, 10:00 Hrs [IST] Boehringer Ingelheim’s bio ...
Pharmabiz13h
Bayer initiates phase II panSOHO study with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumours
Bayer initiates phase II panSOHO study with BAY 2927088 in metastatic or unresectable HER2 mutant solid tumours: Berlin Wednesday, March 5, 2025, 09:00 Hrs [IST] Bayer announced t ...
Pharmabiz14h
Any deviation of approved protocol version is a serious breach
Any deviation of approved protocol version is a serious breach: Dr Arun Bhatt Wednesday, March 5, 2025, 08:00 Hrs [IST] A medical device manufacturer of cameras for health researc ...